4.7 Review

Therapeutic Angiogenesis of Chinese Herbal Medicines in Ischemic Heart Disease: A Review

期刊

FRONTIERS IN PHARMACOLOGY
卷 9, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2018.00428

关键词

ischemic heart disease; treatment status; Chinese herbal medicines; therapeutic angiogenesis; targets

资金

  1. National Natural Science Foundation of China [81703836, 61772531, 11631014, 81673712]
  2. Fundamental Research Funds of Beijing University of Chinese Medicine [2017-JYB-JS-017]
  3. EU Marie Curie Horizon 2020 ITN, iPLACENTA [765274]
  4. Diabetes UK small grant [16/0005453]
  5. Marie Curie Actions (MSCA) [765274] Funding Source: Marie Curie Actions (MSCA)

向作者/读者索取更多资源

Ischemic heart disease (IHD) is one of the primary causes of death around the world. Therapeutic angiogenesis is a promising innovative approach for treating IHD, improving cardiac function by promoting blood perfusion to the ischemic myocardium. This treatment is especially important for targeting patients that are unable to undergo angioplasty or bypass surgery. Chinese herbal medicines have been used for more than 2,500 years and they play an important role alongside contemporary medicines in China. Growing evidence in animal models show Chinese herbal medicines can provide therapeutic effect on IHD by targeting angiogenesis. Identifying the mechanism in which Chinese herbal medicines can promote angiogenesis in IHD is a major topic in the field of traditional Chinese medicine, and has the potential for advancing therapeutic treatment. This review summarizes the progression of research and highlights potential pro-angiogenic mechanisms of Chinese herbal medicines in IHD. In addition, an outline of the limitations of Chinese herbal medicines and challenges they face will be presented.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据